Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 16 citing articles:

Tumor-infiltrating T lymphocytes: A promising immunotherapeutic target for preventing immune escape in cholangiocarcinoma
Sijia Hua, Xinyi Gu, Hangbin Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117080-117080
Open Access | Times Cited: 5
Cancer-associated fibroblasts in hepatocellular carcinoma: heterogeneity, mechanisms and therapeutic targets
Yutong Li, Mawieh Hamad, Eyad Elkord
Hepatology International (2025)
Closed Access
Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinoma
Yizhe Zhang, Yunshu Ma, Ensi Ma, et al.
Cancer Drug Resistance (2025)
Open Access
Midnolin Correlates With Anti‐Tumour Immunity and Promotes Liver Cancer Progression Through β‐Catenin
Shaobo Huang, Jinling Zhang, Ting He, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 6
Open Access
CTNNB1 syndrome mouse models
Duško Lainšček, Vida Forstnerič, Špela Miroševič
Mammalian Genome (2025)
Open Access
Metabolomics Analysis of Functional Activity Changes in Residual Tumour Cells After IOCS Treatment
Lai-Wei You, Jinhuo Wang, Dan Yin, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 6
Open Access
The Roles of H3K9me3 Writers, Readers, and Erasers in Cancer Immunotherapy
Urszula Oleksiewicz, Monika Kuciak, Anna Jaworska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11466-11466
Open Access | Times Cited: 2
Extending inflamed-class signature to predict immune checkpoint inhibitor-based combination therapy in hepatocellular carcinoma
Wenhua You, Chupeng Hu, Mengya Zhao, et al.
Gut (2024), pp. gutjnl-333375
Closed Access | Times Cited: 1
Common diagnostic biomarkers and molecular mechanisms of Helicobacter pylori infection and inflammatory bowel disease
Minglin Zhang, Tong Liu, Lijun Luo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Advances in the Study of Mechanisms by Which the Matrix Metalloproteinase Family Regulates the Development of Breast Cancer
一航 李
Advances in Clinical Medicine (2024) Vol. 14, Iss. 08, pp. 765-772
Closed Access
Targeting metalloproteases is a promising strategy to enhance immunotherapy responses by overcoming immune exclusion in hepatocellular carcinoma
Marina Bárcena‐Varela, Pedro Berraondo
Gut (2024) Vol. 73, Iss. 6, pp. 890-891
Closed Access
Integration of Single-Cell and Spatial Transcriptome Sequencing Identifies CDKN2A as a Senescent Biomarker in Endothelial Cells Implicating Hepatocellular Carcinoma Malignancy
Yue Ma, Chenhe Yi, Ning Cai, et al.
Research Square (Research Square) (2024)
Open Access
Decoding the molecular landscape: A novel prognostic signature for uveal melanoma unveiled through programmed cell death-associated genes
Zibin Liu, Lili Yu, Jian Lai, et al.
Medicine (2024) Vol. 103, Iss. 18, pp. e38021-e38021
Open Access
Advances in clinical and basic research for hepatocellular carcinoma in China: a 2023 review
Pengxiang Wang, Yun‐Fan Sun, Jia Fan
Clinical Cancer Bulletin (2024) Vol. 3, Iss. 1
Open Access
Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA
Mohammad S. Alzahrani, Bandar Almutairy, Yusuf S. Althobaiti, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1947-1964
Closed Access
Integration of single-cell and spatial transcriptome sequencing identifies CDKN2A as a senescent biomarker in endothelial cells implicating hepatocellular carcinoma malignancy
Yue Ma, Chenhe Yi, Ning Cai, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 11
Open Access
Enhancing inhibitory effect in SMMC-7721 hepatoma cells through combined treatment of gallic acid and hUC-MSCs-Exos
Qiang Zhang, Liying Han, Xi Luo, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113704-113704
Closed Access
Decoding β-catenin associated protein-protein interactions: Emerging cancer therapeutic opportunities
Yue Yan, Yiting Gong, Xiaohui Liang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1880, Iss. 1, pp. 189232-189232
Closed Access
Page 1

Scroll to top